Symposia: Outcomes Research: Myeloid Malignancies
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, MDS, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bacterial, Lymphomas, Non-Hodgkin lymphoma, APL, MPN, Epidemiology, Elderly, Fungal, Plasma Cell Disorders, B Cell lymphoma, CML, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), T Cell lymphoma, Chronic Myeloid Malignancies, CMML, Health disparities research, Education, Supportive Care, Diseases, Patient-reported outcomes, Treatment Considerations, Infectious Diseases, Biological therapies, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Registries, Young adult , Myeloid Malignancies, Survivorship, Study Population, Human, Transplantation (Allogeneic and Autologous)
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, MDS, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bacterial, Lymphomas, Non-Hodgkin lymphoma, APL, MPN, Epidemiology, Elderly, Fungal, Plasma Cell Disorders, B Cell lymphoma, CML, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), T Cell lymphoma, Chronic Myeloid Malignancies, CMML, Health disparities research, Education, Supportive Care, Diseases, Patient-reported outcomes, Treatment Considerations, Infectious Diseases, Biological therapies, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Registries, Young adult , Myeloid Malignancies, Survivorship, Study Population, Human, Transplantation (Allogeneic and Autologous)
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH